BCG intravesical instillations: recommendations for side-effects management.
about
The role of mycobacterial cell wall nucleic acid complex in the treatment of bacillus Calmette-Guérin failures for non-muscle-invasive bladder cancerBacillus Calmette-Guerin (BCG) immunotherapy for bladder cancer: current understanding and perspectives on engineered BCG vaccineBacillus Calmette-Guérin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literatureUpdate on intravesical agents for non-muscle-invasive bladder cancerUse of bacille Calmette-Guérin in superficial bladder cancer.Bladder cancer: epidemiology, diagnosis, and management.Myobacterium bovis peri-prosthetic hip infection with successful prosthesis retention following intravesical BCG therapy for bladder carcinomaCUA guidelines on the management of non-muscle invasive bladder cancer.Electrical neuromodulatory therapy in female voiding dysfunction.Phase II study of intravesical therapy with AD32 in patients with papillary urothelial carcinoma or carcinoma in situ (CIS) refractory to prior therapy with bacillus Calmette-Guerin (E3897): a trial of the Eastern Cooperative Oncology Group.Emerging intravesical therapies for management of nonmuscle invasive bladder cancerPancreatic and psoas abscesses as a late complication of intravesical administration of bacillus Calmette-Guerin for bladder cancer: a case report and review of the literature.Bacillus Calmette-Guérin treatment of non-muscle invasive bladder cancer.Granulomas of the penis: a rare complication of intravesical therapy with Bacillus Calmette-Guerin.Intravesical bacillus Calmette-Guérin instillation therapy for non-muscle-invasive bladder cancer following solid organ transplantation.Tackling non-muscle invasive bladder cancer in the clinic.Complications following intravesical bacillus Calmette-Guerin treatment for bladder cancer: a case series of 22 patients.Intravesical bacillus Calmette-Guérin instillation in non-muscle-invasive bladder cancer: A review.Mycobacterium bovis spondylodiscitis after intravesical Bacillus Calmette-Guérin therapy.Efficacy and safety of bladder hydrodistension for decreased bladder capacity induced by intravesical BCG therapy.Penile tuberculosis following intravesical Bacille Calmette-Guérin immunotherapy.Factors affecting valrubicin response in patients with bacillus Calmette-Guérin-refractory bladder carcinoma in situ.Transient anuria requiring nephrostomy after intravesical bacillus Calmette-Guérin instillations for superficial bladder cancer.Natural course of asymptomatic abnormal prostate findings incidentally detected by CT after intravesical BCG therapy.Bacille Calmette-Guérin intravesical instillation and erectile function: is there a concern?Determinants of quality of life of bladder cancer survivors five years after treatment in France.
P2860
Q26770422-2715CF1D-A83B-4E36-98C8-F4CB58262A24Q27006765-75C6D8C7-AFCF-4D3C-AE87-87CBEA6AF95BQ27021357-368C7111-2F13-4E88-A9E8-AE2878075955Q34584575-DDEF72D3-A4CF-4811-8D0A-CD7A77722CBEQ34788204-77E324A8-0B92-4F8C-A4F7-CDDF3D7C97DBQ34983298-9EE6F165-A6C8-4639-AA6D-BD164622C932Q36276438-8207BC00-2EDE-43AE-B5AA-A5BEC8A69CB6Q36326208-C0AE079A-3571-479E-8B60-7604A986820BQ36566842-84663082-E508-4224-A079-5B81F355299EQ37221184-B4FCEE47-BE50-46B8-B346-7906DCCCE2CCQ37283563-6BBE5E07-CB8A-4BFF-97B1-65DB8E84B34AQ37633934-CDF5998C-FD9C-44DB-A483-0009B3DE9B4FQ37811051-30A59F84-7F04-4D3B-A99A-CD7835DF64DFQ37944174-D92FF5C7-CCDE-4BBC-BCB5-4EF3194C82D0Q38093779-399106FF-5028-4B4D-AF5C-2C6ADC95CC35Q39209020-27004410-AA54-4E56-AFB3-663C7A291366Q39363055-47F3D202-A687-4AE4-BBF9-DBBE7365E728Q39457058-5A0BA079-0EAC-49C8-8D6F-042ADC70C788Q39521777-97886DAE-6310-44B2-9785-26E5A55AAAE2Q40473380-CEA7D165-67E8-4213-9A25-F382C976A80AQ40575662-F5469024-13A7-47CE-9278-E1276B4F4C57Q42600757-6635F5C5-4436-4502-BDBB-F78145DA6EA9Q50736111-A74F7CDF-6AD7-4EB4-8314-063654728D42Q50900853-E84E8098-3518-4D49-9A21-A124AEA0FA1BQ53238563-3ADD00CE-3C08-4EBD-9D1F-5C00DA5E4FF4Q53378647-6C2FAEFD-F0E3-4FC6-8722-7DE9FE74C037
P2860
BCG intravesical instillations: recommendations for side-effects management.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
BCG intravesical instillations: recommendations for side-effects management.
@ast
BCG intravesical instillations: recommendations for side-effects management.
@en
type
label
BCG intravesical instillations: recommendations for side-effects management.
@ast
BCG intravesical instillations: recommendations for side-effects management.
@en
prefLabel
BCG intravesical instillations: recommendations for side-effects management.
@ast
BCG intravesical instillations: recommendations for side-effects management.
@en
P2093
P356
P1433
P1476
BCG intravesical instillations: recommendations for side-effects management.
@en
P2093
Desgrandchamps F
Malavaud B
Rischmann P
P356
10.1159/000052381
P407
P478
37 Suppl 1
P577
2000-01-01T00:00:00Z